Potential availability of saliva-based reverse transcription-quantitative polymerase chain reaction in extensive screening for asymptomatic individuals as a business continuity strategy during the coronavirus disease 2019 pandemic
Respir Med Res. 2024 Jan 14:85:101085.
doi: 10.1016/j.resmer.2024.101085.
Online ahead of print.
1 Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, 162-8655, Tokyo, Japan.
2 Center for Clinical Sciences, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku-ku, 162-8655, Tokyo, Japan. Electronic address: mkimura@hosp.ncgm.go.jp.
3 SB Coronavirus Inspection Center Corp., 1-7-1, Kaigan, Minato-ku, Tokyo, 105-0022, Japan.